Loading clinical trials...

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD". | Clinical Trials | Clareo Health

RECRUITINGNA

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Follow-up During the Peripubertal Period of Preterm Children (Under 35 Weeks of Amenorrhea) Included in the "EPIPOD" Protocol : Evaluation of Insulin Resistance

NCT04945369•Nantes University Hospital

View on ClinicalTrials.gov

Summary

Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood. It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass. It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood. Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol. Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.

Eligibility

Age

8 - 14 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Children hospitalised at the Nantes University Hospital in the neonatal period
•With a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol
•Born prematurely (under 35 weeks of amenorrhea)
•Included in the Lift cohort with follow-up up to 7 years
•Aged between 8 and 14 years at inclusion

Exclusion Criteria

•Children with an isolated metabolic disease: insulin-dependent diabetes; endocrine disease (Cushing's, hypothyroidism)
•Age of 15 years or more
•with a chromosomal anomaly
•with contraindicating measurement of the BOP-POD: ventilatory support, continuous parenteral feeding, elimination stoma
•Refusal of either parent or child

Locations (1)

Nantes University Hospital

Nantes, France

Key Dates

Start Date

February 2, 2022

Primary Completion Date

February 2, 2028

Completion Date

February 2, 2028

Last Updated

November 14, 2025

Enrollment

114

ESTIMATED participants

Conditions

Preterm Children

Interventions

clinical and biological measurements and questionnaires

OTHER

Contacts

Anne FRONDAS, Doctor

CONTACT

+33 2 40 08 34 83 anne.frondas@chu-nantes.fr

Preterm Birth and Social Cognition

NCT03007095

Preterm Children

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 14, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions